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Molecular Insights into Polyubiquitin Chain
Assembly: Crystal Structure of the
Mms2/Ubc13 Heterodimer
the chemical structure of the polyubiquitin chain (Chau
et al., 1989; Deng et al., 2000; Finley et al., 1994; Hofmann
and Pickart, 1999; Koegl et al., 1999; Pickart, 2000;
Spence et al., 1995). For example, polyubiquitin chains
linked through Lys48 (K48-chains) are the principal sig-
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nal for proteolysis by 26S proteasomes (Chau et al.,School of Medicine
1989; Finley et al., 1994), whereas Lys63-linked chains2 Department of Biochemistry
(K63-chains) are required for postreplicative DNA repairSchool of Public Health
(Hofmann and Pickart, 1999; Spence et al., 1995), IKK3 Howard Hughes Medical Institute
activation (Deng et al., 2000), translational regulationJohns Hopkins University
(Spence et al., 2000), and certain cases of ubiquitin-Baltimore, Maryland 21205
dependent endocytosis (Galan and Haguenauer-Tsapis,
1997). Blocking K63-chain assembly has no effect on
proteasomal degradation in vivo (Spence et al., 1995),Summary
and IKK activation can be reconstituted in vitro in the
definitive absence of proteasomes (Deng et al., 2000).While the signaling properties of ubiquitin depend on
IKK activation is selectively inhibited by free K63-chains,the topology of polyubiquitin chains, little is known
and not K48-chains (Deng et al., 2000). Thus, while theconcerning the molecular basis of specificity in chain
precise signaling functions of K63-chains remain to beassembly and recognition. UEV/Ubc complexes have
defined, it is highly unlikely that these chains signalbeen implicated in the assembly of Lys63-linked poly-
proteolysis by proteasomes.ubiquitin chains that act as a novel signal in postreplica-
The ubiquitination of a protein substrate involves thetive DNA repair and IB kinase activation. The crystal
formation of an isopeptide bond between a substratestructure of the Mms2/Ubc13 heterodimer shows the
lysine residue and the C-terminal carboxyl group of ubi-active site of Ubc13 at the intersection of two channels
quitin Gly76. This reaction is accomplished through thethat are potential binding sites for the two substrate
sequential actions of three enzymes: a ubiquitin-activat-ubiquitins. Mutations that destabilize the heterodimer
ing enzyme (E1), a ubiquitin-conjugating enzyme (E2 orinterface confer a marked UV sensitivity, providing di-
Ubc), and a ubiquitin-protein ligase (E3) (Hershko andrect evidence that the intact heterodimer is necessary
Ciechanover, 1998). E1 forms an initial thioester bondfor DNA repair. Selective mutations in the channels
with the carboxyl terminus of ubiquitin in an ATP-depen-suggest a molecular model for specificity in the as-
dent reaction. Ubiquitin is then transferred to the activesembly of Lys63-linked polyubiquitin signals.
site cysteine of the E2. Isopeptide bond formation re-
sults from attack on the E2 bound ubiquitin by a lysine
Introduction
residue of the substrate. This final reaction usually re-
quires the participation of an E3 that binds both the E2
Protein modification by ubiquitin serves a signaling ubiquitin thioester and the protein targeted for ubiquiti-
function in diverse biological processes, including cell nation (Hershko and Ciechanover, 1998). Lysine resi-
cycle progression (Koepp et al., 1999), oncogenesis dues within ubiquitin may also serve as substrates, lead-
(Joazeiro and Weissman, 2000; Joazeiro et al., 1999), ing to the formation of diubiquitin and, eventually,
and antigen presentation (Rock and Goldberg, 1999). polyubiquitin chains. While the overall folds of mono-
The ability of ubiquitin to signal substrate proteolysis meric E2 enzymes, both alone and in complex with E3
by the 26S proteasome underlies many of ubiquitin’s ligases, have been determined (Cook et al., 1992; Huang
cellular functions (Hershko and Ciechanover, 1998). et al., 1999; Jiang and Basavappa, 1999; Worthylake
However, ubiquitin also serves as a nonproteolytic sig- et al., 1998; Zheng et al., 2000), a plausible molecular
nal in DNA repair (Jentsch et al., 1987; Spence et al., mechanism for catalysis or specificity in ubiquitin-sub-
1995) and IB kinase (IKK) activation (Chen et al., 1996). strate conjugation has not yet emerged. Furthermore,
Ubiquitin conjugation also serves a signaling function the key question of how polyubiquitin chains are selec-
in endocytosis that leads to proteolysis in the lysosome/ tively linked through specific lysine residues has not
vacuole (Hicke, 1999), and ubiquitin conjugation can previously been addressed.
modulate the structural organization of multiprotein as- Ubiquitin E2 variant (UEV) proteins play a central role
semblies (Kaiser et al., 2000). in the assembly of K63-linked polyubiquitin chains (Deng
The biologically active ubiquitin signal frequently con- et al., 2000; Hofmann and Pickart, 1999; Sancho et al.,
sists of a polyubiquitin chain in which successive ubiqui- 1998; Ulrich and Jentsch, 2000). UEVs are similar in
tins are joined through isopeptide bonds involving spe- sequence to E2s, but lack the active site cysteine resi-
cific lysine residues of ubiquitin. In some cases, the fate due, indicating that UEVs must serve a fundamentally
of a ubiquitin-conjugated protein can be correlated with different role in ubiquitin conjugation from that per-
formed by canonical E2s (Broomfield et al., 1998; San-
cho et al., 1998). The UEVs characterized to date func-4 Correspondence: cwolberg@jhmi.edu
tion together with a canonical E2, Ubc13, in the5 Present address: Laboratory of Synthetic Protein Chemistry, The
Rockefeller University, New York, New York 10021. assembly of K63-chains (Deng et al., 2000; Hofmann
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Figure 1. Structure of the Mms2/Ubc13 Complex
(A) Cartoon representation of Mms2/Ubc13 complex with Mms2 in blue and Ubc13 in green. Helices and strands are labeled. The side chain
of the active site residue Ubc13-Cys87 is shown in yellow.
(B) Alignment of Ubc13 from complex, green, with Ubc13 alone structure, gray. Only C are shown, plus Ubc13-Cys87 for orientation.
(C) Primary sequence alignment of selected E2s and UEVs. The E2 active site cysteine position is outlined by a tan box; the Mms2 insertion
containing F8 is shown in green. Ubc13 surface residues that are part of channel 1 are shown in magenta. Residues of UEVs and Ubc13s
that make up channel 2 are shown in blue. Alignment was done with DALIGN.
and Pickart, 1999). The yeast UEV protein, Mms2, is whose architecture is likely to be conserved among the
known UEV/E2 complexes. We present mutagenesis ex-required together with Ubc13 for RAD6/RAD18-depen-
dent postreplicative DNA repair in yeast (Broomfield et periments that demonstrate the importance of the qua-
ternary arrangement of the heterodimer for in vitro enzy-al., 1998; Hofmann and Pickart, 1999). In vitro, Mms2
and Ubc13 form a complex that catalyzes the assembly matic activity and in vivo DNA repair, and identify
residues that participate in binding the two ubiquitinof K63-chains, which function as a specific signal in
the DNA repair pathway (Hofmann and Pickart, 1999; proteins that become linked during conjugation. Based
on our structural results and the catalytic properties ofSpence et al., 1995). A related human UEV1a/Ubc13
heterodimer synthesizes K63-chains that are required the mutant enzymes, we propose a model for molecular
specificity in the assembly of K63-linked polyubiquitinfor IKK activation (Deng et al., 2000). Both the yeast
and human heterodimers interact with a RING domain chains.
protein that may be either a cognate E3 or a substrate of
the respective E2/UEV heterodimers (Deng et al., 2000; Results and Discussion
Ulrich and Jentsch, 2000).
Although UEV proteins were initially thought to be Overall Structure of the Mms2/Ubc13 Heterodimer
Mms2 and Ubc13 form a T-shaped dimer that arisescatalytically inert (Broomfield et al., 1998; Koonin and
Abagyan, 1997; Sancho et al., 1998), the Mms2/Ubc13 from asymmetric interactions between the two E2-like
monomers (Figure 1A). Ubc13 displays the canonicaland UEV1a/Ubc13 heterodimers catalyze the assembly
of K63-chains in the absence of any other factor besides / E2 fold, with a root-mean-square deviation (rmsd)
in C positions of 1.6 A˚, when compared with Ubc4E1 (Deng et al., 2000; Hofmann and Pickart, 1999). Chain
assembly is absolutely dependent on the presence of (Cook et al., 1993). The active site cysteine residue (C87)
is contained in a long loop near the short helix 2 thatMms2 or UEV1a in the respective heterodimers, but the
role played by the UEV subunit in catalysis and specific- follows  strand 4 (Figures 1A and 1C). Mms2, the UEV
protein, adopts a fold similar to Ubc13 and other E2ity has not been understood. Here we report the 1.6 A˚
resolution structure of the Mms2/Ubc13 heterodimer, enzymes, but with several notable differences. The seven
Structures of Mms2/Ubc13
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Figure 2. The Mms2/Ubc13 Binding Inter-
face Contains Both Hydrophobic and Polar
Surfaces
(A) Mms2/Ubc13 heterodimerization inter-
face. Ubc13 is displayed as a surface with
Mms2 interface residues in light blue.
(B) F8A-Mms2 (light blue) environment show-
ing hydrophobic contacts with Ubc13 resi-
dues E55, L56, Y57, and R70 (green). The
Ubc13 backbone is shown in green.
(C) E55-Ubc13 environment highlighting hy-
drogen bonds that bridge the interface
(black). The Mms2 backbone shown in blue,
the Ubc13 backbone in green.
amino-terminal residues of Mms2, which participate in mutant against Ubc13 showed that it had a 50- to 100-
fold reduced affinity for wild-type Ubc13 as measuredcomplex formation with Ubc13, adopt a conformation
that is atypical of E2s. This conformation allows the N by the ability to catalyze the formation of K63-linked
diubiquitin (Figure 3A), while direct binding assays re-terminus to participate in the dimer interface (Figure 1A).
In addition, Mms2 is 16 residues shorter than Ubc13, vealed no detectable binding (Figure 3B). The Ubc13-
E55A mutation also strongly reduces the affinity ofand Mms2 residues C-terminal to helix 3 do not adopt
the E2 fold. The vestigial active site loop of Mms2 (resi- Ubc13 for wild-type Mms2 (Figure 3B). Neither mutation
affects Ubc13 ubiquitin thioester formation (data notdues surrounding Mms2-Gln94) is 44 A˚ away from the
Ubc13 active site loop and is unlikely to function in shown), demonstrating that the decrease in chain syn-
thesis (Figure 3A and data not shown) is not due tocatalysis (Figure 1A, see below).
diminished recognition of the E2 active site by E1. The
biochemical properties of these mutant proteins indi-The Mms2/Ubc13 Binding Interface
cate that the targeted residues make important contribu-The asymmetric interface of the Mms2/Ubc13 hetero-
tions to complex stability.dimer is formed by packing of Mms2 helix 1 against
Deletion of the MMS2 or UBC13 gene inactivates theUbc13  strands S3 and S4 (Figure 2A). In addition, loop
error-free branch of the yeast RAD6/RAD18 DNA repairresidues 30–38 from Mms2 interact with Ubc13 residues
pathway and sensitizes cells to DNA-damaging agents72–83 (Figure 2A) located in S4 and in the loop leading
such as UV light (Broomfield et al., 1998; Brusky et al.,to helix 2. The interface, which is stabilized by both van
2000; Hofmann and Pickart, 1999; Xiao et al., 2000) (solidder Waals and hydrogen bonding interactions, buries a
versus dashed line, Figure 3C). To test the biologicaltotal surface area of 1,435 A˚2. A particularly striking fea-
consequences of disrupting the heterodimer interface,ture is the insertion of Phe8 of Mms2 into a hydrophobic
we examined the effect of expressing Mms2-F8A to-pocket formed by residues Tyr57, Leu56, Glu55, and
gether with wild-type Ubc13, or Ubc13-E55A togetherArg70 of Ubc13 (Figure 2B). Phe8 is located in an inser-
with wild-type Mms2, in yeast strains lacking endoge-tion that is unique to UEVs (Figure 1C, green). Leu83 of
nous copies of both genes. Each mutant protein, whenUbc13 also participates in hydrophobic contacts with
coexpressed with its wild-type partner, confers a DNAMms2 residues Leu14, Leu30, Asp34, Ile36, and Met38.
repair defect that is essentially identical to that of theProminent hydrogen bonds are formed within the inter-
starting double null strain (Figure 3C, compare openface between Ubc13-Glu55 and Mms2-Asn7, as well as
circles and squares to inverted triangles). A similar resultbetween Ubc13-Arg70 and the carbonyl group of Mms2-
is obtained when the two mutant proteins are coex-Ile36 (Figure 2C).
pressed (upright triangles, Figure 3C). The failure of thePoint mutations were introduced at the Mms2/Ubc13
mutant proteins to support repair was not due to poorinterface in order to verify the importance of the contacts
expression, as shown by Western blot analysis (Figureseen in the crystal structure for heterodimerization in
3D). These results verify the importance of Mms2-Phe8vitro. Alanine was substituted for residue Phe8 of Mms2,
and Ubc13-Glu55 for complex stabilization and provideboth because it is a key residue mediating binding to
direct evidence that the Mms2/Ubc13 complex, and notUbc13 and because it is found in the two-residue inser-
tion unique to UEVs (above). Titrating the Mms2-F8A just its individual constituents, is required for DNA repair.
Cell
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Figure 3. Biochemical Properties of Mms2/Ubc13 Interface Mutants
(A) Purified wild-type Mms2 (filled circles) or Mms2-F8A (open circles) was titrated against Ubc13 (0.5 M) in 10 min assays of 125I-diubiquitin
synthesis (Experimental Procedures).
(B) Direct binding assays. A slight excess of Ubc13 was mixed with His10-Mms2 prior to incubation with nickel beads and elution with increasing
salt concentration (50 mM to 1 M NaCl). The resin was stripped with EDTA at the end. In the bottom two strips, a slight excess of Mms2 was
used; the reversed mobilities of Mms2 and Ubc13 are due to the use of different SDS-PAGE systems.
(C) Intact complex interface is required for biological activity. His10-Mms2 and Ubc13-HA3 (wild-type or mutant proteins as indicated) were
expressed from separate centromeric plasmids under the control of the respective endogenous promoters in strain SUB62 (Finley et al., 1994)
deleted for both endogenous genes. The tagged wild-type proteins are fully functional based on protection against UV light (R.H. and C.P.,
unpublished data). Inverted triangles, cells transformed with the two empty vectors; filled circles, wild-type (wt) Mms2 plus wt Ubc13; open
circles, wt Mms2 plus E55A-Ubc13; squares, F8A-Mms2 plus wt Ubc13; triangles, F8A-Mms2 plus E55A-Ubc13.
(D) Expression of interface mutants in yeast cells. Selected liquid culture aliquots were lysed and extracts were probed by Western blotting
for expression of H10Mms2 and Ubc13-HA3. “Std,” purified H10Mms2 protein. Purified E55A-Ubc13 migrates aberrantly in this SDS-PAGE
system (data not shown).
Interactions between Mms2/Ubc13 and Ubiquitin alter the surface properties of each channel without im-
peding heterodimer formation (Figure 4, blue). We thenUbiquitin polymerization by the Mms2/Ubc13 complex
requires the positioning of two ubiquitin molecules in tested the mutant proteins for their ability to catalyze
the formation of K63-diubiquitin in the presence of E1an orientation that allows Lys63 of one molecule (the
acceptor) to react with Gly76 of the other (donor) mole- and the relevant wild-type partner protein. The channel
2 mutation, Ubc13-D81A, significantly impaired chaincule bound to Ubc13-Cys87. Examination of the hetero-
dimer surface surrounding Ubc13-Cys87 reveals three assembly (Figure 5A), while remaining fully competent
for heterodimerization (Figure 3B) and thioester forma-distinct channels (Figure 4, green) that lead toward the
active site cysteine (yellow). The channels are concave tion (data not shown). Substitution of arginine at this
position (Ubc13-D81R) has an even more dramatic ef-near Ubc13-Cys87 and become shallower distal to the
active site (Figure 4). Channel 1 lies solely on the surface fect, abolishing chain assembly completely (Figure 5A)
without affecting E2-ubiquitin thioester formation (dataof Ubc13, while channels 2 and 3 are formed by residues
from both proteins. The surface of channel 1 is hy- not shown).
The channel 1 mutation, Ubc13-A110R, significantlydrophobic, with a small acidic region near the active
site. Channel 2 is also mainly hydrophobic, while channel inhibits chain assembly as assayed with wild-type Mms2
(Figure 5A), without inhibiting thioester bond formation3 contains many charged residues, both basic and
acidic. To test the importance of these channels in K63- (data not shown). Instead, inhibition of chain assembly
reflects a 4-fold reduction in the chemical rate of isopep-chain formation, we introduced mutations designed to
Structures of Mms2/Ubc13
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Figure 4. Channels and Interfering Mutations
The heterodimer is shown as a surface. The
three channels referred to in the text are col-
ored green and numbered, interfering muta-
tions are shown in blue. Ubc13-Cys87 is
shown in yellow. The figure was generated with
VMD (Humphrey et al., 1996) and RENDER
(Merritt and Bacon, 1997).
tide bond formation (as determined in a pulse-chase 3 mutation, Mms2-E12R, had no effect on heterodimer
formation with wild-type Ubc13 (Figure 3B) or on steady-experiment, data not shown). These results are most
simply explained if the A110R mutation interferes with state chain assembly (Figure 5A). The complexes car-
rying mutations in channels 1 or 3 display Km values forthe positioning of the covalently bound donor ubiquitin
in channel 1 so that it is less favorably oriented for the acceptor ubiquitin that are indistinguishable from
that of the wild-type complex, suggesting that theseattack by Lys63 of the acceptor ubiquitin. The channel
Figure 5. Biochemical Properties of Channel Mutants
(A) Diubiquitin assembly assay. D77-ubiquitin and K63R-ubiquitin (117 M each) served as acceptor and donor, respectively, in incubations
containing 2 M Mms2/Ubc13 and 0.1 M E1. (Coomassie-stained gel.)
(B) Binding of inert K63-tetraubiquitin to channel 1 and 3 mutants (filled circles, wild-type Mms2 plus wild-type Ubc13; crosses, wild-type
Mms2 plus Ubc13-A110R; open circles, Mms2-E12R plus wild-type Ubc13). Competition was measured in assays of 125I-diubiquitin formation
as described in Experimental Procedures.
(C) Binding of inert K63-tetraubiquitin to channel 2 mutant (filled circles, wild-type Mms2 plus wild-type Ubc13; open circles, wild-type Mms2
plus Ubc13-D81A).
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mutations do not impede acceptor binding (data not Model for Lysine63-Linked Polyubiquitin
Chain Assemblyshown). To analyze acceptor ubiquitin binding more rig-
Based on the structural and biochemical data presentedorously, we used wild-type Mms2/Ubc13 complex to
here, we have constructed a model for the K63-chainassemble K63-tetraubiquitin that was constrained to
assembly reaction performed by the Mms2/Ubc13 com-bind to the acceptor site, but is chemically inert. Specifi-
plex (Figure 6). Two ubiquitins were manually dockedcally, we prevented thioester formation by placing an
onto the Mms2/Ubc13 structure, placing a donor ubiqui-extra residue (D77) at the chain’s proximal terminus,
tin in channel 1 and an acceptor ubiquitin in channel 2and blocked isopeptide bond formation by mutating the
(Figure 6, purple). The donor ubiquitin was positioneddistal Lys63 to arginine (Piotrowski et al., 1997). In
to place the Gly76 carbonyl group within 3 A˚ of theassays with wild-type Mms2/Ubc13 heterodimer, the
active site Cys87, while maximizing the shape comple-purified tetramer competed effectively with a mono-
mentarity of ubiquitin to channel 1 and minimizing stericmeric acceptor, ubiquitin-D77 (filled circles, Figures 5B
clashes. Ubiquitin with an I44A substitution is specifi-and 5C). Competition by the tetramer was unaffected
cally defective in binding to the acceptor (versus donor)by the channel 1 (A110R-Ubc13) or channel 3 (E12R-
site, suggesting that Ile44 may be located on the surfaceMms2) mutations (crosses and open circles, Figure 5B).
of ubiquitin that contacts the acceptor site (A. RagurajThese results demonstrate that neither channel 1 nor
and C.P., unpublished results). We therefore positionedchannel 3 serves as a binding site for the acceptor ubi-
the acceptor ubiquitin by requiring that ubiquitin Lys63quitin. In contrast, the Ubc13-D81A mutation in channel
approach Ubc13-Cys87 via channel 2 and that ubiquitin
2 led to diminished competition by the ubiquitin tetramer
Ile44 contact the heterodimer surface. We further re-
(Figure 5C), consistent with channel 2 serving as the quired that the -amino group of Lys63 be within 3 A˚
site for acceptor ubiquitin binding. of the Ubc13-Cys87 thiol (Figure 6)—a distance that
The results of our studies suggest that channel 1, positions the lysine side chain for nucleophilic attack on
which is composed entirely of Ubc13 residues, defines the carbonyl group of the thioester bond. In the resulting
the binding site for the donor ubiquitin. The proposed model, Ile44 of the acceptor ubiquitin contacts Mms2
role for this channel is consistent with the requirement in the region of Ile57 (Figure 6). Shape constraints alone
that all E2 enzymes bind a donor ubiquitin and with the were taken into account during manual model building.
high degree of sequence conservation among E2s in A similar model was arrived at using the automated
residues that line channel 1 (Figure 1C, magenta). Fur- docking program, 3-D Dock (Gabb et al., 1997), which
ther support comes from NMR studies of a Ubc2b-ubi- takes both electrostatics and steric constraints into ac-
quitin oxyester adduct that demonstrated an interaction count. The program was used to produce a set of solu-
between this E2 and ubiquitin in the region of channel tions for the docking of a single ubiquitin monomer on
1 (Miura et al., 1999). Our evidence supports a role for the surface of the Mms2/Ubc13 heterodimer. When no
channel 2 in acceptor ubiquitin binding, as the Ubc13- constraints are imposed on the docking program, the
D81A mutation has a dramatic affect on diubiquitin syn- highest-ranking solutions have the ubiquitin docked into
thesis without affecting heterodimerization (Figure 3B) either the donor site that lies on Ubc13 (channel 1), or
or thioester bond formation. The proposed role in ac- on the corresponding surface of Mms2 near the vestigial
active site. The latter set of solutions, however, does notceptor ubiquitin binding is supported by the effect of
place Lys63 (or any other lysine) of the docked ubiquitinthe D81A mutation in acceptor site-specific competition
sufficiently close to the enzyme active site to be a plausi-assays (Figure 5C). Furthermore, the 9.2 A˚ distance be-
ble model for acceptor ubiquitin binding. In order totween the active site Cys87 and Ubc13-Asp81 make it
identify other possible docking solutions that could rep-highly unlikely that this channel 2 residue is directly
resent the binding of acceptor ubiquitin, the results ofinvolved in catalysis. Residues from Ubc13 that fall
the unconstrained search were sorted to eliminate solu-within channel 2 are conserved between yeast and hu-
tions that failed to place Lys63 of ubiquitin within 4.5 A˚man Ubc13 (both of which form a UEV/E2 complex), but
of the active site cysteine, Ubc13-Cys87. The remainingare not well conserved in other E2s that do not catalyze
solutions contain a ubiquitin docked into the acceptorthe formation of K63-linked polyubiquitin chains (Figure
site in essentially the same orientation as that obtained1C, blue), consistent with the proposed role of these
by the manual docking procedure. Interestingly, neitherresidues in acceptor ubiquitin binding.
manual nor computational approaches to positioning
To examine possible conformational changes within
an acceptor ubiquitin with Lys48 near the active site
Ubc13 that might occur as a result of Mms2 binding, cysteine yielded a plausible model, consistent with the
we determined the structure of Ubc13 alone. The 2.0 A˚ proposed role of channel 2 of the heterodimer in orient-
structure is very similar to that of Ubc13 in the hetero- ing ubiquitin for K63-linked chain formation.
dimer, with an rmsd of 0.8 A˚ for C atoms. An alignment The model presented here provides a straightforward
of Ubc13 alone and Ubc13 from the heterodimer (Figure explanation for linkage specificity in polyubiquitin chain
1B) demonstrates the similarity, and shows that complex assembly. As is the case for other E2 enzymes, Ubc13
formation is unlikely to affect donor ubiquitin binding to acts as a donor that transfers a covalently bound ubiqui-
channel 1. Additionally, there are no appreciable differ- tin to a lysine residue on an acceptor protein. Mms2,
ences in the orientation of residues proximal to Cys87 the catalytically inactive E2-like protein, binds to Ubc13
in the two structures. A similar lack of E2 conformational and thereby forms an acceptor ubiquitin binding channel
perturbation was reported in the structures of UbcH7 at a junction between the two proteins. The residues
with two different cognate E3s (Huang et al., 1999; Zheng that line the acceptor channel orient the bound ubiquitin
so that the Ubc13 bound donor ubiquitin is transferredet al., 2000).
Structures of Mms2/Ubc13
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Figure 6. Model for Interaction of Mms2/
Ubc13 Complex (Surface) with Rad5 (Red)
and Two Ubiquitin Proteins (Purple)
The donor Ub and acceptor Ub were posi-
tioned to place the C termini of the donor Ub
and K63 of the acceptor Ub within 3 A˚ of the
active site thiol (yellow) while avoiding steric
clashes. Other modeling criteria are de-
scribed in the text. The acceptor ubiquitin is
at the lower left; the donor ubiquitin is at the
right.
specifically to Lys63 of the acceptor ubiquitin. This tooncogene c-Cbl, contain RING domains (Joazeiro and
Weissman, 2000). The c-Cbl/UbcH7 cocrystal structuremodel predicts that the use of different lysine residues
in chain assembly will be associated with interactions revealed that the E2 (UbcH7) binds the RING domain of
c-Cbl by inserting phenylalanine and proline side chainsbetween distinct ubiquitin surfaces and specific chain-
assembling enzymes/complexes. Consistent with this into a groove of the E3 RING domain (Zheng et al.,
2000). We used the c-Cbl RING domain to construct aidea, the I44A mutation in ubiquitin, which blocks bind-
ing to the Mms2/Ubc13 acceptor site, is permissive for homology model of the Rad5 RING domain bound to
Mms2/Ubc13 by assuming that Ubc13 binds to the Rad5the assembly of K48-chains by two different enzymatic
pathways (Beal et al., 1996). RING domain in a manner similar to the c-Cbl/UbcH7
interaction (Figure 6). The model suggests that interac-
tion of the Mms2/Ubc13 and UEV1a/Ubc13 complexesProposed RING-Heterodimer Interactions
The Mms2/Ubc13 complex has been shown to interact with their RING partner proteins Rad5 (Ulrich and
Jentsch, 2000) and Traf6 (Deng et al., 2000) will notwith the Rad5 helicase, a component of the RAD6/
RAD18 pathway that also features a zinc binding RING occlude any interactions with either donor or acceptor
ubiquitin. The binding of RING domain proteins to UEV/domain (Brusky et al., 2000; Johnson et al., 1992; Ulrich
and Jentsch, 2000). Rad5 associates with the hetero- Ubc13 complexes should therefore not alter linkage
specificity in chain assembly, in agreement with resultsdimer via a direct interaction with Ubc13 (Ulrich and
Jentsch, 2000). Many E3 enzymes, including the pro- obtained in biochemical studies of Traf6 and the UEV1a/
Table 1. Statistics from the Crystallographic Analysis
Crystal Ubc13 Alone Mms2/Ubc13 Complex
X-ray source RAXIS IV NSLS X4A
Temperature 298K 100K
Resolution (A˚) 2.0 1.6
Observations 55,421 185,078
Unique Reflections 17,787 36,126
Completeness (%) 93.6 (83.2) 98.8 (97.9)
Overall I/(I) 27.8 (4.4) 23.0 (3.8)
Rsym (%) 5.3 (22.3) 6.7 (35.9)
Mosaicity 0.33 0.78
Refinement Statistics
Total atoms 2,529 2,535
R factor (%) 18.8 20.3
Rfree (%) 26.1 23.9
Rmsd bonds (A˚) 0.0084 0.0097
Rmsd angles () 1.53 1.60
Rsym  	h	i|Ih,I 
 Ih|	h	iIh,i for the intensity (I) of i observations of reflection h.
R factor  	|Fobs 
 Fcalc|/	|Fobs|, where Fobs and Fcalc are the observed and calculated structure factors, respectively. Rfree  R factor calculated
using 5% of the reflection data chosen randomly and omitted from the start of refinement. Statistics for the outer shell are in parentheses.
Rmsd: root mean square deviations from ideal geometry.
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4T2 (Amersham-Pharmacia). To create pH10-Mms2, the His10-Mms2Ubc13 complex (Deng et al., 2000). Although numerous
sequence under the control of the endogenous MMS2 promoterexamples of RING E3 proteins are known (Joazeiro and
was cloned into a URA3-marked version of the centromeric vectorWeissman, 2000), RING domain proteins can also be
pRS316. To create pUbc13-HA3, the Ubc13 sequence (with its intron)substrates of modification by ubiquitin (Buschmann et was cloned downstream of the endogenous UBC13 promoter in
al., 2000). It remains to be determined whether Traf6 a centromeric LEU2-marked vector specifying a C-terminal triple-
hemaglutinin (HA) tag (gift of O. Kershner). Antibodies against theand Rad5 are E3 enzymes or substrates of the respective
polyHis and HA tags were purchased from Santa Cruz. MutationsUEV/Ubc13 complexes.
were introduced by whole-plasmid PCR using appropriate muta-
genic primers via the Quick-Change mutagenesis kit (Stratagene).
Conclusions All mutations were verified by DNA sequencing.
Linkage specificity in ubiquitin chain assembly allows
for the generation of a diverse set of polyubiquitin chains Protein Purification
whose cellular functions are distinct. The Mms2/Ubc13 His10Mms2 was expressed in BL21pJY2 cells as described (Hofmann
and Pickart, 1999; You et al., 1999), purified on nickel beads underheterodimer exclusively catalyzes the assembly of K63
denaturing conditions (4 M Urea, 50 mM HEPES [pH 8.0], 0.5 Mpolyubiquitin chains, and this catalysis is dependent on
NaCl, 5% gylcerol, 1 mM -mercaptoethanol, 1 M AEBSF), andthe binding of Mms2 to Ubc13; Mms2 or Ubc13 alone
refolded by dialysis. Ubc13 was expressed using pGEX-ScUbc13will not assemble chains of any linkage type. The asym-
and released from the GST-Ubc13 fusion protein (immobilized on
metric Mms2/Ubc13 complex is stabilized by a combi- GSH beads) by thrombin cleavage. The resulting protein initiates
nation of electrostatic and hydrophobic contacts that with Ala2. For crystallography, the His10 tag was removed from Mms2
with Factor Xa, the Mms2 and Ubc13 were mixed in a 1:1 ratio, andare, in part, mediated by residues of Mms2—notably
the complex was purified on a MonoQ column in buffer containingAsn7 and Phe8—that are unique to UEVs (Figure 1C).
5% glycerol. The reconstituted complex was active in K63-chainResidues making up the interface of the yeast Mms2/
synthesis prior to crystallization (data not shown). For biochemicalUbc13 complex are highly conserved in human UEV1a
assays, mutant and wild-type Mms2 and Ubc13 proteins were puri-
and Ubc13. Thus, it appears highly likely that the human fied separately and mixed in the assay. In the case of D81R-Ubc13,
UEV1a/Ubc13 complex, which assembles K63-chains the GST fusion was eluted with reduced glutathione prior to cleavage
with thrombin, then mixed with His10Mms2. The complex was thenimportant in IKK activation, shares a very similar archi-
purified by nickel bead chromatography. The intact tagged version oftecture to the Mms2/Ubc13 complex. Consistent with
Mms2 was used for biochemical studies. The tagged protein is fullythis idea, the two complexes share striking biochemical
functional in DNA repair in vivo (R.H. and C.P., unpublished data).similarities (Deng et al., 2000; Hofmann and Pickart,
1999) and the overexpression of human UEV1a com-
Crystallization and Data Collection
plements the DNA repair defect of yeast deleted for Purified Ubc13 (12 mg/ml) was dialyzed into 10 mM HEPES (pH 8.0),
the MMS2 gene (Thomson et al., 1998; Xiao et al., 10 mM NaCl, 5 mM DTT. Crystals were grown using the hanging
1998). We have demonstrated the importance, in vivo, drop vapor diffusion method at 20C by mixing equal volumes of
protein with a reservoir solution containing 30% PEG5000-MME,of heterodimer formation by our finding that mutations
200 mM ammonium sulfate, 50 mM MES (pH 6.5), 2 mM DTT. Datawhich inhibit Mms2/Ubc13 complex formation produce
were collected at room temperature at the Cu-K edge using aa defect in DNA repair equivalent to a null mutation in
RAXIS-IV image plate detector equipped with double-focusing mir-
either gene. rors. Crystals formed in space group P21 with unit cell dimensions
A striking feature of the UbcH7/c-Cbl and UbcH7/E6- a  26.0 A˚, b  129.4 A˚, c  42.9 A˚,   96.4 and contained two
AP E2-E3 structures is that while the E3 is required for molecules in the asymmetric unit. The Mms2/Ubc13 complex was
dialyzed into buffer containing 10 mM HEPES (pH 8.0), 10 mM NaCl,assembly of polyubiquitin chains on the substrate, the
1 mM EDTA, 5 mM b-mercaptoethanol, 5% glycerol and concen-E3 does not provide any residues for chemical catalysis
trated to10 mg/ml by ultrafiltration. Crystals were obtained by the(Huang et al., 1999; Zheng et al., 2000). Indeed, the
hanging drop vapor diffusion method at 20C by mixing the complex
closest approach of any E3 residue to the E2 active site with an equal volume of reservoir solution containing 35% PEG
thiol is 15 A˚. In view of this unexpected feature, it 1000, 50 mM Tris (pH 7.5), 2 mM DTT. The crystals formed in space
has been suggested that catalysis reflects principally group P21 with unit cell dimensions a  53.0 A˚, b  63.6 A˚, c 
43.1 A˚,   105.8 and contained one complex in the asymmetrican induced proximity of substrate (bound to the E3) and
unit. Crystals were frozen at 100 K using reservoir solution supple-ubiquitin (bound to the E2). The Mms2/Ubc13 complex
mented with 20% glycerol as the cryoprotectant. Diffraction datafollows this trend, as no Mms2-derived side chain ap-
were collected at beamline X4A of NSLS (l 0.912 A˚) and processed
proaches Cys87 closely enough to be a credible candi- with DENZO and SCALEPACK (Otwinowski and Minor, 1997). Crys-
date for a chemical catalyst. Rather, Mms2 provides a tallographic statistics are shown in Table 1.
platform that binds the acceptor ubiquitin in an orienta-
tion that allows only Lys63, and not Lys48, to approach Structure Determination and Refinement
The structure of Ubc13 alone was solved by molecular replacementthe active site. These results show for the first time how
with the program MOLREP (Collaborative Computational Project,a simple molecular scaffold can provide the high degree
1994) using the structure of Ubc4 (Protein Data Bank Id code 1QCQ)of specificity necessary in ubiquitin chain assembly and
(Cook et al., 1993) as the search model. The structure was built with
suggests a general model for how binding of accessory the model building program XFIT (McRee, 1999). The model was
proteins to E2 enzymes can guide the conjugation of refined using CNS (Brunger et al., 1998) and contains residues (3–28,
ubiquitin with substrates. 30–150) from molecule A, residues (3–29, 31–149) from molecule B,
and 190 water molecules.
The structure of the Mms2/Ubc13 complex was solved by firstExperimental Procedures
determining the position of Ubc13 using MOLREP (Vagin and Teply-
akov, 1997) using Ubc13 as the search model. A molecular replace-Plasmids and Antibodies
Plasmid pET16b-ScMms2 has been described (Hofmann and Pic- ment solution was also obtained for residues 38–77 of Mms2, using
Ubc13 32–71 as the search model, and phases were then calculatedkart, 1999). In pGEX-ScUbc13, the yeast Ubc13 coding sequence
was cloned downstream of the thrombin cleavage site of pGEX- for the entire complex. ARP/wARP (Lamzin and Wilson, 1993) was
Structures of Mms2/Ubc13
719
used for initial model building of Mms2 and further model building sential for proteolytic targeting. Proc. Natl. Acad. Sci. USA 93,
861–866.was done using XFIT (McRee, 1999). The model was refined using
CNS (Brunger et al., 1998) and contains Ubc13 residues 2–152, Broomfield, S., Chow, B.L., and Xiao, W. (1998). MMS2, encoding a
Mms2 residues (2–19, 24–137), and 276 water molecules. Alternative ubiquitin-conjugating-enzyme-like protein, is a member of the yeast
conformations are included for Ubc13 residues Val69, Leu88, Trp129 error-free postreplication repair pathway. Proc. Natl. Acad. Sci. USA
and Mms2 residues Cys26, Ile57, Ile81, and Arg129. Mms2 residues 95, 5678–5683.
20–23 are disordered.
Brunger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P.,
Grosse-Kunstleve, R.W., Jiang, J.S., Kuszewski, J., Nilges, M.,
Chain Assembly Assays
Pannu, N.S., et al. (1998). Crystallography & NMR system: A new
Two assays were used, with both carried out under conditions that
software suite for macromolecular structure determination. Acta.
yield diubiquitin as the sole product in order to facilitate quantitative
Crystallogr. D Biol. Crystallogr. 54, 905–921.
rate measurements. In the first assay (Hofmann and Pickart, 1999),
Brusky, J., Zhu, Y., and Xiao, W. (2000). UBC13, a DNA-damage-a high concentration of D77-ubiquitin (117 mM) served as acceptor
inducible gene, is a member of the error-free postreplication repairwhile a low concentration of 125I-ubiquitin (5 mM) served as donor.
pathway in Saccharomyces cerevisiae. Curr. Genet. 37, 168–174.Incubations (conditions as in Hofmann and Pickart, 1999) containing
0.2 mM each of Mms2 and Ubc13 (and 0.1 mM E1) were sampled Buschmann, T., Fuchs, S.Y., Lee, C.G., Pan, Z.Q., and Ronai, Z.
(2000). SUMO-1 modification of Mdm2 prevents its self-ubiquitina-in the linear rate period and resolved by SDS-PAGE prior to counting
the excised 125I-diubiquitin band. Studies of competition by K63- tion and increases Mdm2 ability to ubiquitinate p53. Cell 101, 753–
762.tetraubiquitin employed the same assay, but with a reduced concen-
tration of D77-ubiquitin (25 mM). In the second assay, D77-ubiquitin Chau, V., Tobias, J.W., Bachmair, A., Marriott, D., Ecker, D.J., Gonda,
and K63R-ubiquitin (117 mM each) served as acceptor and donor, D.K., and Varshavsky, A. (1989). A multiubiquitin chain is confined
respectively, in incubations containing 2 mM each of Mms2 and to specific lysine in a targeted short-lived protein. Science 243,
Ubc13 (with 0.1 mM E1). The diubiquitin product was visualized by 1576–1583.
SDS-PAGE and Coomassie staining. Pulse-chase assays to mea-
Chen, Z.J., Niles, E.G., and Pickart, C.M. (1991). Isolation of a cDNA
sure the intrinsic rate of ubiquitin-ubiquitin conjugation were carried
encoding a mammalian multiubiquitinating enzyme (E225K) and over-out essentially as described previously (Chen et al., 1991). The pulse
expression of the functional enzyme in Escherichia coli. J. Biol.
contained 4 mM each of Mms2 and Ubc13 and 2 mM of 125I-ubiquitin;
Chem. 266, 15698–15704.
the chase was initiated by adding 117 mM wild-type ubiquitin as
Chen, Z.J., Parent, L., and Maniatis, T. (1996). Site-specific phos-acceptor. The method for assembly of K63-tetraubiquitin was modi-
phorylation of IB by a novel ubiquitination-dependent protein ki-fied from that employed previously to make K48-tetraubiquitin (Pio-
nase activity. Cell 84, 853–862.trowski et al., 1997) and will be described in detail elsewhere (R.H.
and C.P., unpublished data). Collaborative Computational Project, N. (1994). CCP4. Acta. Cryst.
D50, 760–763.
Direct Assay of Mms2/Ubc13 Binding Cook, W.J., Jeffrey, L.C., Sullivan, M.L., and Vierstra, R.D. (1992).
In most cases, His10Mms2 was mixed with a slight excess of Ubc13 Three-dimensional structure of a ubiquitin-conjugating enzyme (E2).
and then immobilized on nickel beads and then mixed with Ubc13 J. Biol. Chem. 267, 15116–15121.
in a buffer containing 50 mM Tris (pH 8), 0.2 mg/ml BSA. The immobi-
Cook, W.J., Jeffrey, L.C., Xu, Y., and Chau, V. (1993). Tertiary struc-
lized complex was washed with this buffer and then eluted with
tures of class I ubiquitin-conjugating enzymes are highly conserved:
increasing concentrations of NaCl in the same buffer. For Mms2-
crystal structure of yeast Ubc4. Biochemistry 32, 13809–13817.
F8A and its control, a slight excess of Mms2 was immobilized first
Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaugh-and then mixed with wild-type Ubc13 prior to proceeding as de-
ter, C., Pickart, C., and Chen, Z.J. (2000). Activation of the IB kinasescribed above.
complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme
complex and a unique polyubiquitin chain. Cell 103, 351–361.UV Sensitivity Measurements
The MMS2 and UBC13 genes were deleted from strain SUB62 (Finley Finley, D., Sadis, S., Monia, B.P., Boucher, P., Ecker, D.J., Crooke,
S.T., and Chau, V. (1994). Inhibition of proteolysis and cell cycleet al., 1994) using URA3-marked disruption plasmids followed by
selection against the marker using 5-fluoorotic acid (Alani et al., progression in a multiubiquitination-deficient yeast mutant. Mol.
Cell. Biol. 14, 5501–5509.1987; Hofmann and Pickart, 1999). The resulting double null strain
was transformed with pH10-Mms2 and pUbc13-HA3 (above) that Gabb, H.A., Jackson, R.M., and Sternberg, M.J. (1997). Modelling
specified either wild-type or mutant versions of the respective pro- protein docking using shape complementarity, electrostatics and
teins (Mms2-F8A or Ubc13-E55A). The resulting strains were grown biochemical information. J. Mol. Biol. 272, 106–120.
on selective medium and tested for UV sensitivity as described
Galan, J., and Haguenauer-Tsapis, R. (1997). Ubiquitin Lys63 is in-
(Hofmann and Pickart, 1999).
volved in ubiquitination of a yeast plasma membrane protein. EMBO
J. 16, 5847–5854.
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